Health News Review
  • Mar 31 2010

    Book: Superbug – The Fatal Menace of MRSA

    My friend and fellow Minnesotan Maryn McKenna has written a powerful book on the drug-resistant staph infection called MRSA or methicillin-resistant Staphyloccocus aureus. The book was just published last week and is already drawing lots of due praise. It’s also an interesting story of a path taken by a former daily newspaper health journalist. McKenna [...]

    No Comments
  • Mar 31 2010

    $638,000 to prevent one heart attack

    Duff Wilson’s New York Times piece, “Risks Seen in Cholesterol Drug Use in Healthy People,” raises important questions about expanding the market for statins. Especially strong was his breakdown of absolute risk reduction – and of cost impact. Here’s how he ended the piece: “Critics said the claim of cutting heart disease risk in half [...]

    5 Comments
  • Mar 30 2010

    Another predictable “chocolate may be good for you” story – this time for Easter

    Just a month and a half ago, a health care journalist wrote on Twitter, “Just once it would be nice to get through Valentine’s Day without some new goofball health story about chocolate.” She didn’t get her way. On February 11, we reviewed a HealthDay story, “Dark Chocolate May Lower Stroke Risk.” Well, substitute Easter [...]

    No Comments
  • Mar 30 2010

    Before you blame Twitter for health misinformation…..

    A paper in the current American Journal of Infection Control looks at how quickly – and erroneously – health information can spread via Twitter. ABC reports that one of the authors “said that even a single inaccurate tweet is broadcast on average to tens of thousands of people.” Please allow us to issue that same [...]

    No Comments
  • Mar 30 2010

    Why news about animal research requires BIG qualifiers

    Every week on HealthNewsReview.org, we criticize stories for failing to emphasize that a given piece of research was in animals – and for failing to discuss the limitations of such research. Here’s more evidence about why that’s important. The journal PLoS Biology has published an analysis, “Publication Bias in Reports of Animal Stroke Studies Leads [...]

    1 Comment
  • Mar 29 2010

    Chicago Tribune profiles active surveillance for prostate cancer

    We just don’t see many stories that profile someone who declines aggressive treatment for prostate cancer and chooses watchful waiting – or active surveillance – instead. But that’s what Judith Graham of the Chicago Tribune delivered yesterday, explaining that: “…for the first time it’s being endorsed for large numbers of men by a major medical [...]

    1 Comment
  • Mar 26 2010

    The Colorectal Cancer Screening Guidelines Mess

    Before we close out colon cancer awareness month, I want to draw attention to another important paper in the journal Gastroenterology, “Understanding differences in the guidelines for colorectal cancer screening,” by Thomas Imperiale and David Ransohoff. (subscription required, published online March 16 ahead of print). The authors start with the broad message that guideline-setting in [...]

    4 Comments
  • Mar 25 2010

    Sharply different reactions to JAMA psychiatry & pharma commentary

    The Journal of the American Medical Association this week published a commentary, “Psychiatrists’ Relationships With Pharmaceutical Companies: Part of the Problem or Part of the Solution?” by the chief of the National Institute of Mental Health. On his blog, psychiatrist Daniel Carlat praises the “power (and courage) of the country’s chief psychiatrist calling his own [...]

    2 Comments
  • Mar 24 2010

    Asking more “unpleasant questions about mammography screening”

    There’s been surprisingly little coverage of an analysis by the Nordic Cochrane group in this week’s BMJ that concludes: “We were unable to find an effect of the Danish screening programme on breast cancer mortality. The reductions in breast cancer mortality we observed in screening regions were similar or less than those in non-screened areas [...]

    6 Comments
  • Mar 24 2010

    Stopping clinical trials may distort evidence about risks and benefits

    A study in this week’s Journal of the American Medical Association, “Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects,” gives another troubling look at how inflated may be some of the claims about research findings. One of the authors, Victor Montori, MD, of the Mayo Clinic, is quoted on a Mayo blog: [...]

    No Comments